SM, U., Y, T., MA, G., B, M., M, W., HA, A., . . . AB, S. (2022). Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: Relevance to Alzheimer's disease treatment. Heliyon, 8(9), e10613. https://doi.org/10.1016/j.heliyon.2022.e10613
Chicago Style (17th ed.) CitationSM, Uzairu, et al. "Kinetics and Computational Study of Butyrylcholinesterase Inhibition by Methylrosmarinate: Relevance to Alzheimer's Disease Treatment." Heliyon 8, no. 9 (2022): e10613. https://doi.org/10.1016/j.heliyon.2022.e10613.
MLA (9th ed.) CitationSM, Uzairu, et al. "Kinetics and Computational Study of Butyrylcholinesterase Inhibition by Methylrosmarinate: Relevance to Alzheimer's Disease Treatment." Heliyon, vol. 8, no. 9, 2022, p. e10613, https://doi.org/10.1016/j.heliyon.2022.e10613.